vs
Side-by-side financial comparison of AMERICAN SHARED HOSPITAL SERVICES (AMS) and Celcuity Inc. (CELC). Click either name above to swap in a different company.
American Shared Hospital Services offers turnkey outsourced solutions for advanced radiotherapy, stereotactic radiosurgery and diagnostic imaging equipment to healthcare facilities. It eliminates high upfront capital costs for hospitals, operates primarily across North America, and also serves Latin America and select Asia-Pacific markets, catering to both public and private hospital segments.
Celcuity Inc. is a clinical-stage biotechnology company specializing in oncology. It develops personalized cancer treatment solutions through its proprietary functional cell analysis technology, targeting unmet medical needs for patients with hard-to-treat solid tumors, with primary operations in the U.S. and partnerships across global biopharmaceutical networks.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.7M | — | ||
| Q3 25 | $7.2M | — | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.1M | — | ||
| Q4 24 | $9.1M | — | ||
| Q3 24 | $7.0M | — | ||
| Q2 24 | $7.1M | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | $-631.0K | — | ||
| Q3 25 | $-17.0K | — | ||
| Q2 25 | $-280.0K | — | ||
| Q1 25 | $-625.0K | — | ||
| Q4 24 | $-1.3M | — | ||
| Q3 24 | $-207.0K | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $119.0K | — |
| Q4 25 | 11.7% | — | ||
| Q3 25 | 22.1% | — | ||
| Q2 25 | 23.1% | — | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | 35.3% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 35.0% | — | ||
| Q1 24 | 41.1% | — |
| Q4 25 | -18.1% | — | ||
| Q3 25 | -4.8% | — | ||
| Q2 25 | -7.7% | — | ||
| Q1 25 | -21.3% | — | ||
| Q4 24 | -20.2% | — | ||
| Q3 24 | -12.7% | — | ||
| Q2 24 | -0.0% | — | ||
| Q1 24 | -1.6% | — |
| Q4 25 | -8.2% | — | ||
| Q3 25 | -0.2% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | -10.2% | — | ||
| Q4 24 | -14.6% | — | ||
| Q3 24 | -3.0% | — | ||
| Q2 24 | 51.0% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $-0.21 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $0.55 | — | ||
| Q1 24 | $0.02 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
